AU2002236120A1 - Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors - Google Patents

Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors

Info

Publication number
AU2002236120A1
AU2002236120A1 AU2002236120A AU2002236120A AU2002236120A1 AU 2002236120 A1 AU2002236120 A1 AU 2002236120A1 AU 2002236120 A AU2002236120 A AU 2002236120A AU 2002236120 A AU2002236120 A AU 2002236120A AU 2002236120 A1 AU2002236120 A1 AU 2002236120A1
Authority
AU
Australia
Prior art keywords
cyclooxygenase
enzyme inhibitors
fast dissolving
dissolving tablets
tablets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002236120A
Other languages
English (en)
Inventor
Vinod Kumar Arora
Rajiv Malik
Deepak Murpani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of AU2002236120A1 publication Critical patent/AU2002236120A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002236120A 2001-02-27 2002-02-27 Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors Abandoned AU2002236120A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN189/DEL/01 2001-02-27
IN189DE2001 2001-02-27
PCT/IB2002/000587 WO2002067894A2 (en) 2001-02-27 2002-02-27 Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors

Publications (1)

Publication Number Publication Date
AU2002236120A1 true AU2002236120A1 (en) 2002-09-12

Family

ID=11097035

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002236120A Abandoned AU2002236120A1 (en) 2001-02-27 2002-02-27 Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors

Country Status (9)

Country Link
EP (1) EP1367994A2 (cs)
AU (1) AU2002236120A1 (cs)
CZ (1) CZ20032568A3 (cs)
HU (1) HUP0400098A2 (cs)
IS (1) IS6932A (cs)
OA (1) OA12686A (cs)
PL (1) PL363771A1 (cs)
SK (1) SK11802003A3 (cs)
WO (1) WO2002067894A2 (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7815937B2 (en) 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
CN1638739A (zh) * 2000-08-18 2005-07-13 法玛西雅厄普约翰美国公司 治疗成瘾性障碍的化合物
TR200301552A1 (tr) * 2003-09-18 2005-10-21 Nobel İlaç Sanayi̇ Ve Ti̇caret A. Ş. Rofekoksib' in yeni oral farmakolojik formülasyonları.
GB0724707D0 (en) * 2007-12-19 2008-01-30 Burke Michael H A process for the preparation of an orally administered unit dose tablet
US10350171B2 (en) 2017-07-06 2019-07-16 Dexcel Ltd. Celecoxib and amlodipine formulation and method of making the same
CN108653225B (zh) * 2018-08-15 2021-01-08 湖北舒邦药业有限公司 一种尼美舒利制剂及其制备方法
CN112569178B (zh) * 2020-12-29 2022-09-09 南京百泽医药科技有限公司 一种帕瑞昔布药物组合物制备方法及用作舌下制剂的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2178686A1 (en) * 1995-06-13 1996-12-14 Leslie G. Humber Oral formulations of s(+)-etodolac
EP0945134A1 (de) * 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation
WO2001085134A1 (en) * 2000-05-12 2001-11-15 Emcure Pharmaceuticals Ltd Pharmaceutical solid compositions and process for the production of mouth dissolving tablets

Also Published As

Publication number Publication date
WO2002067894A2 (en) 2002-09-06
SK11802003A3 (sk) 2004-06-08
EP1367994A2 (en) 2003-12-10
PL363771A1 (en) 2004-11-29
OA12686A (en) 2006-06-21
HUP0400098A2 (hu) 2004-04-28
CZ20032568A3 (cs) 2004-04-14
IS6932A (is) 2003-08-27
WO2002067894A3 (en) 2002-12-19

Similar Documents

Publication Publication Date Title
AU2002331311A1 (en) Heterocyclic compounds that are inhibitors of the enzyme dpp-iv
AU2003248872A1 (en) Hiv integrase inhibitors
AU2003238042A1 (en) Cyclooxygenase-2 inhibitors
AU2003259921A1 (en) Complementary trading of interests
AU2001265182A1 (en) Inhibitors of matrix metalloproteinases
AU2002322802A1 (en) Thrombin inhibitors
AU2002236120A1 (en) Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors
AU2002306734A1 (en) Inhibitors of plasmepsins
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
AU2003295638A1 (en) NOVEL INHIBITORS OF Beta-LACTAMASE
AU2003269984A1 (en) Protease inhibitors
AU2002316552A1 (en) Inhibitor of t cell activation
AU7957000A (en) Cyclooxygenase-2 expression inhibitors
AU2002351076A1 (en) Thrombin inhibitors
AU2002342682A1 (en) Protease inhibitors
AU2003249320A1 (en) Novel inhibitors of ubiquitin isopeptidases
EP1573685A3 (en) Secure point of sale imageable substrate
AU2002305868A1 (en) Inhibitors of reggamma
AU2003263738A1 (en) Protease inhibitors
AU2003224874A1 (en) INHIBITORS OF SERINE AND METALLO-ss-LACTAMASES
AU2002363791A1 (en) Protease enzyme inhibitors
AU2002950185A0 (en) Enzyme inhibitors
AU2003279244A1 (en) Biosynthesis of hif
AU2002258749A1 (en) Inhibitors of glycosaminoglycans
AU2002253633A1 (en) 20-hydroxyeicosatetraenoic acid production inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase